文献速递其他结缔组织病系统性红斑狼疮

英国儿童结缔组织病肺部筛查现状:多中心审计与建议标准

Current UK practice in pulmonary screening in paediatric connective tissue disease: UK multi-centre audit and proposed standards.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该审计旨在为儿童结缔组织病(CTD)的肺部筛查制定标准并评估英国三级儿童风湿病中心的实践。共纳入128例jSLE、jDM、jSSc或jMCTD患者,发现肺部受累比例因CTD类型而异,且筛查不一致导致肺部受累可能被低估。采用建议标准有望改善肺部表现的识别、监测和管理。

要点

  • 儿童CTD肺部受累比例:jSLE 39.7%、jDM 12.2%、jSSc 57.1%、jMCTD 25.0%。
  • 随访中定期评估肺部症状和体征的患者≤50%,筛查不一致。
  • 诊断和随访时肺功能测试和间质性肺病影像学使用不一致。

核心结论

  • 儿童CTD尚无普遍公认的肺部筛查标准,导致中心间和医生间实践不一致。
  • 采用建议标准可能改善肺部表现的识别、监测和管理,并规范实践。

研究设计与样本

  • 审计通过识别和回顾相关国家和国际指南来制定审计标准。
  • 数据来自英国五个中心,纳入过去12个月内诊断的jSLE、jDM、jSSc或jMCTD患者,共128例符合纳入标准。

主要发现

  • 肺部受累比例:jSLE 27/68(39.7%),jDM 5/41(12.2%),jSSc 4/7(57.1%),jMCTD 3/12(25.0%)。
  • 随访中定期评估肺部症状和体征的患者≤50%。
  • 诊断和随访时间质性肺病的肺功能测试和影像学使用不一致。
  • 肺部受累可能因筛查不一致而被低估。

临床怎么用

  • 建议采用提出的标准以改善儿童CTD肺部表现的识别、监测和管理。
  • 应规范肺部筛查实践,包括定期评估症状体征及合理使用肺功能测试和影像学。

局限性

  • 肺部受累可能被低估,因筛查不一致。
  • 数据来自五个英国中心,可能不反映更广泛实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pulmonary manifestations of CTDs are associated with morbidity and mortality. Early recognition through screening ensures appropriate monitoring and management. The aim of this audit was to define standards for pulmonary screening in CTDs and assess practice in UK tertiary paediatric rheumatology centres. METHODS: Relevant national and international guidelines were identified and reviewed to inform audit standards. Data were collected from five UK centres. Patients with a diagnosis of juvenile SLE (jSLE), juvenile DM (jDM), juvenile SSc (jSSc) or juvenile MCTD (jMCTD) seen within the last 12 months were included. RESULTS: A total of 128 patients met inclusion criteria and identified pulmonary involvement varied between the CTDs: 27/68 (39.7%) in jSLE, 5/41 (12.2%) in jDM, 4/7 (57.1%) in jSSc and 3/12 (25.0%) in jMCTD. Pulmonary involvement is likely to be underestimated due to inconsistent screening, with ≤50% of patients having regular assessment of pulmonary symptoms and signs during follow-up, and inconsistent use of lung function testing and imaging for interstitial lung disease both at diagnosis and during follow-up. CONCLUSION: There are no universally recognized standards on pulmonary screening in juvenile CTDs, leading to inconsistency across centres and between practitioners. However, adoption of the proposed standards would likely improve recognition, monitoring and management of pulmonary manifestations, standardize practice, and inform and improve future guidance and research.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Southwood G, Mageean K, Ahmid M, et al. Current UK practice in pulmonary screening in paediatric connective tissue disease: UK multi-centre audit and proposed standards. Rheumatology (Oxford). 2026. PMID: 41385289. doi:10.1093/rheumatology/keaf659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。